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THE CHANGING ROLE OF VACUUM ASSISTED BIOPSY OF THE BREAST
Over the past 25 years the diagnosis and management of breast disease has been greatly assisted by the development of new needle biopsy techniques with ever improving technology. Fine needle aspiration biopsy (FNAB) was quickly superseded in the 1990's by automated core needle biopsy (CNB) techniques and the early 2000's saw the widespread introduction of vacuum assisted breast biopsy (VAB) devices.
The impetus for the transition from FNAB to CNB was the improved sensitivity and specificity of core needle biopsy over the fine needle technique 1,2, and the fact that FNAB was associated with a significantly high inadequacy rate 3 . CNB also provided superiority of diagnosis in being able to distinguish between insitu and invasive malignancy by histological assessment 4 , and additionally by the fact the immunohistochemical and molecular profiling of tumour samples is able to be undertaken providing information in relation to ER's, PR's and HER 2 for purposes of planning systemic treatments and neoadjuvant drug therapies 5 . Additionally the modern management of breast cancer patients importantly necessitates the ability to achieve a tissue diagnosis prior to definitive cancer surgery so that proper consultation can be undertaken with the patient being fully informed prior to definitive surgical treatment. Indeed current preferred practice would dictate that the use of surgical excisional biopsy to establish whether a breast lesion is benign or malignant should only be used infrequently and under exceptional circumstances. BreastScreen Australia in its National Accreditation Standards requires that more 75% of malignancies should be diagnosed without the need for open surgical biopsy 6 .
Both CNB and VAB offer the ability to achieve a diagnosis nonoperatively for breast lesions, however recent reports have demonstrated that VAB may have superiority in certain circumstances in terms of its diagnostic ability, and in its capacity to achieve complete excision of breast lesions.
The vacuum assisted core biopsy device is essentially a core biopsy needle with an associated suction chamber and rotating cutter. The vacuum draws tissue into the aperture of the needle,
which is then sliced off with a rotating cutter. Whilst some of the earlier VAB devices required the needle to be extracted from the breast so that the specimen could be retrieved, most current VAB devices transport the specimen by suction into a port chamber without the need to remove the needle from the biopsy site, thus enabling multiple tissue samples to be taken through a single skin VAB can now be utilized with all of the usual breast imaging modalities including mammography, ultrasound and MRI. Ultrasound is the most easily utilized and preferred imaging to guide the performance of VAB and from the perspective of the Breast Surgeon who utilizes ultrasound in his practice this a readily employable technique. Mammographic stereotactic percutaneous VAB and MRI guided VAB are utilized when the breast lesion of concern is only visible on either of these modalities. Stereotactic needle biopsy is most commonly used for microcalcification and MRI has a particular application in younger women with dense breast parenchyma, particularly those at high risk of familial breast cacner.
In the diagnostic context the indications for VAB are continuing to expand. One of the most useful roles of VAB is when there is discordance between the breast imaging findings and the FNAC or core biopsy histology. Wang et al 7 in a study of 62 patients in whom lesions were found to be ultrasound
imaging-histologic discordant following CNB, the subsequent use of VAB was associated with the discovery of malignancy in up to 23% of cases.
There is also a good argument for advocating the use of VAB for selected cases in BI-RADS Category 4, particularly 4a, which is associated with a low but significant risk of malignancy in the range of 2-10%, as VAB has been demonstrated to have a very high negative predictive rate (99%) 8 .
VAB is also particularly useful in the context of small lesions, including both small sonographic lesions < 5mm and very small clusters of microcalcification, both of which are more easily targeted with VAB than with a standard CNB. On the other hand microcalcifications of extreme size and particularly diffuse areas of pleomorphic microcalcification where DCIS is suspected may be more effectively sampled with VAB to improve the probability of detecting or excluding invasive carcinoma in the context of a provisional diagnosis of DCIS. A meta-analysis by Brennan 9 et al which included 52 studies and 7350 cases of DCIS, the underestimation rate of invasive carcinoma for 14 gauge CNB was 30.3% whereas for an 11 gauge VAB this figure was 18.9%.
VAB is also the preferred method of needle intervention for lesions which are very deep or close to the chest wall or very superficial and close the skin or nipple as the VAB mechanism does not involve a 'throw', as is the case for CNB which may be less safe under these circumstances.
VAB of the breast has also been demonstrated to have an increasing therapeutic role. In view of the large sample size which a VAB device can collect, and as multiple samples can be retrieved at each intervention, it is feasible to completely excise breast lesions. The most commonly targeted lesions have been fibroadenomas and numerous studies have now been reported utilizing VAB as an alternative to surgical excision for the management of fibroadenomata 10, 11 . Most studies have reported very high success rates with residual or recurrent lesions found in less than 10-15% of cases. Lesions up to 2.5cm can be effectively removed using VAB and this is most commonly performed under ultrasound guidance. Breast Surgeons upskill themselves in ultrasound and needle biopsy techniques to be able to offer patients this latest technologically optimal care. Breast Surgeons now have access to numerous recognized national and international ultrasound training programs with associated credentialing bodies to appropriately facilitate skills development in this area and it would be essential that surgeons avail themselves of these programs and achieve the necessary accreditation.
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